Bayer | BAYN - Debt


Bayer reported EUR36.45B in Debt for its fiscal quarter ending in December of 2025.





Debt Change Date
Air Liquide EUR 13.64B 1.19B Dec/2025
Akzo Nobel EUR 6.11B 1.25B Mar/2026
Alcon AG USD 5.25B 4.74B Mar/2026
Amarin USD 0 0 Mar/2025
Arkema EUR 4.27B 284.1M Mar/2026
AstraZeneca USD 32.24B 1.68B Jun/2026
BASF EUR 23.67B 460M Mar/2026
Bayer EUR 36.45B 2.93B Dec/2025
Beiersdorf EUR 100M 252M Dec/2025
Corteva USD 3.36B 776M Mar/2026
Covestro EUR 3.14B 571M Dec/2025
Essilor EUR 14.4B 348M Dec/2025
Fresenius EUR 11.9B 28M Mar/2026
Fresenius Medical Care EUR 11.03B 233.8M Mar/2026
Genmab DKK 5.35B 5.2B Mar/2026
Givaudan CHF 5.32B 416M Jun/2024
GlaxoSmithKline GBP 19.06B 1.34B Mar/2026
GRIFOLS EUR 8.52B 1.15B Jun/2026
Henkel EUR 3.71B 3M Dec/2025
Hikma Pharmaceutical USD 1.6B 46M Dec/2025
Johnson Matthey GBP 1.25B 195M Jun/2022
Linde USD 26.32B 672M Mar/2026
Lonza CHF 4.71B 915M Dec/2024
Merck EUR 12.04B 86M Mar/2026
Novartis USD 49.01B 2.02B Jun/2026
Nutrien USD 12.73B 1.22B Jun/2026
Philips EUR 7.47B 632M Jun/2026
PPG Industries USD 7.46B 271M Jun/2026
Roche Holding CHF 33.03B 1.41B Jun/2025
Sanofi EUR 23.58B 3.56B Jun/2026
SAP EUR 7.86B 386M Mar/2026
Solvay EUR 2.24B 40M Jun/2026
UCB EUR 3.03B 12M Dec/2024
Umicore EUR 2.85B 12.08M Dec/2025
Vinci EUR 37.69B 1.64B Dec/2025